Leukotech (patent portfolio) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Leukotech (patent portfolio) General Information
Description
Antibody patent portfolio in Copenhagen, Denmark. The patents relate to antibodies against heparin binding protein (HBP) and biologically active peptides derived from HBP. It addresses the severity of disease development associated with the initial infection and inflammatory processes.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Symbion Science Park, Fruebjergvej 3
- Box 8
- 2100 Copenhagen
- Denmark
Leukotech (patent portfolio) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Leukotech (patent portfolio) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|